Viatris Receives FDA Approval for RYZUMVI Presbyopia Treatment
The FDA approved Viatris’ RYZUMVI (phentolamine ophthalmic solution 0.75%) for treating presbyopia in adults.
Story updates
08:06:00 PM UTC
SquawkNews
Viatris received FDA approval to expand RYZUMVI (phentolamine ophthalmic solution 0.75%) to treat presbyopia in adults. The company is exploring a U.S. partner to commercialize the indication.Material DetailsContext by AI AnalystThis is a regulatory expansion of an already approved eye drop, moving…